Gene-environment interactions and predictors of breast cancer in family-based multi-ethnic groups
Gene-environment interactions and predictors of breast cancer in family-based multi-ethnic groups |
|
https://doi.org/10.18632/oncotarget.25520
Mildred C. Gonzales,
James Grayson,
Amanda Lie,
Chong Ho Yu,
and Shyang-Yun Pamela K. Shiao
|
| 29019-29035 |
The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence
The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence |
|
https://doi.org/10.18632/oncotarget.25528
Shariq S. Khwaja,
Chunyu Cai,
Shahed N. Badiyan,
Xiaowei Wang,
and Jiayi Huang
|
| 29036-29046 |
Oral inflammation promotes oral squamous cell carcinoma invasion
Oral inflammation promotes oral squamous cell carcinoma invasion |
|
https://doi.org/10.18632/oncotarget.25540
Cameron Goertzen,
Hayder Mahdi,
Catherine Laliberte,
Tomer Meirson,
Denise Eymael,
Hava Gil-Henn,
and Marco Magalhaes
|
| 29047-29063 |
A multiomics analysis of S100 protein family in breast cancer
A multiomics analysis of S100 protein family in breast cancer |
|
https://doi.org/10.18632/oncotarget.25561
Patrizia Cancemi,
Miriam Buttacavoli,
Gianluca Di Cara,
Nadia Ninfa Albanese,
Serena Bivona,
Ida Pucci-Minafra,
and Salvatore Feo
|
| 29064-29081 |
An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma
An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25607
Mathias Tesson,
Richa Vasan,
Andreas Hock,
Colin Nixon,
Colin Rae,
Mark Gaze,
and Robert Mairs
|
| 29082-29096 |
InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment
InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment |
|
https://doi.org/10.18632/oncotarget.25624
Masaru Koido,
Yuri Tani,
Satomi Tsukahara,
Yuka Okamoto,
and Akihiro Tomida
|
| 29097-29111 |
Resveratrol prevents p53 aggregation in vitro and in breast cancer cells
Resveratrol prevents p53 aggregation in vitro and in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25631
Danielly C. Ferraz da Costa,
Nathali P.C. Campos,
Ronimara A. Santos,
Francisca Hildemagna Guedes-da-Silva,
Mafalda Maria D.C. Martins-Dinis,
Letícia Zanphorlin,
Carlos Ramos,
Luciana P. Rangel,
and Jerson L. Silva
|
| 29112-29122 |
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25632
Musalula Sinkala,
Nicola Mulder,
and Darren Patrick Martin
|
| 29123-29139 |
PARP1-Erk synergism in proliferating cells
PARP1-Erk synergism in proliferating cells |
|
https://doi.org/10.18632/oncotarget.25633
Leonid Visochek,
and Malka Cohen-Armon
|
| 29140-29145 |
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25635
Sunali Y. Mehta,
Brianna C. Morten,
Jisha Antony,
Luke Henderson,
Annette Lasham,
Hamish Campbell,
Heather Cunliffe,
Julia A. Horsfield,
Roger R. Reddel,
Kelly A. Avery-Kiejda,
Cristin G. Print,
and Antony W. Braithwaite
|
| 29146-29161 |
Collaborating genomic, transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis
Collaborating genomic, transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis |
|
https://doi.org/10.18632/oncotarget.25646
Jin Wang,
Tianfang Wang,
Micah A. Bishop,
John F. Edwards,
Hang Yin,
Stephen Dalton,
Laura K. Bryan,
and Shaying Zhao
|
| 29162-29179 |
Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas
Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas |
|
https://doi.org/10.18632/oncotarget.25650
Kinga Németh,
Nikolette Szücs,
Sándor Czirják,
Lilla Reiniger,
Borbála Szabó,
Gábor Barna,
Katalin Karászi,
Péter Igaz,
Vladimir Zivkovic,
Márta Korbonits,
Attila Patócs,
and Henriett Butz
|
| 29180-29192 |
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition |
|
https://doi.org/10.18632/oncotarget.25670
Sa Rang Kim,
Julia M. Lewis,
Benoit M. Cyrenne,
Patrick F. Monico,
Fatima N. Mirza,
Kacie R. Carlson,
Francine M. Foss,
and Michael Girardi
|
| 29193-29207 |
Circular RNA CpG island hypermethylation-associated silencing in human cancer
Circular RNA CpG island hypermethylation-associated silencing in human cancer |
|
https://doi.org/10.18632/oncotarget.25673
Humberto J. Ferreira,
Veronica Davalos,
Manuel Castro de Moura,
Marta Soler,
Montserrat Perez-Salvia,
Alberto Bueno-Costa,
Fernando Setien,
Sebastian Moran,
Alberto Villanueva,
and Manel Esteller
|
| 29208-29219 |
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25678
Masakazu Yoshida,
Etsuko Yokota,
Tetsushi Sakuma,
Tomoki Yamatsuji,
Nagio Takigawa,
Toshikazu Ushijima,
Takashi Yamamoto,
Takuya Fukazawa,
and Yoshio Naomoto
|
| 29220-29232 |
Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates
Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates |
|
https://doi.org/10.18632/oncotarget.25603
Beiwei Yu,
Dong Dong,
Mingxia Wang,
Yan Guo,
Dandan Yin,
and Fupin Hu
|
| 29233-29237 |
Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants |
|
https://doi.org/10.18632/oncotarget.25579
Natalia Cullell,
Caty Carrera,
Elena Muiño,
Nuria Torres,
Jerzy Krupinski,
and Israel Fernandez-Cadenas
|
| 29238-29258 |
Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy
Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy |
|
https://doi.org/10.18632/oncotarget.25660
Artem Blagodatski,
Margarita Yatsunskaya,
Valeriia Mikhailova,
Vladlena Tiasto,
Alexander Kagansky,
and Vladimir L. Katanaev
|
| 29259-29274 |
Papillary thyroid microcarcinoma (Black Ink)
Papillary thyroid microcarcinoma (Black Ink) |
|
https://doi.org/10.18632/oncotarget.25621
Ersilio Trapanese,
Carmine De Bartolomeis,
Basilio Angrisani,
and Giulio Tarro
|
| 29275-29283 |
Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal |
|
https://doi.org/10.18632/oncotarget.25721
Abhishek D. Garg,
Sanne Elsen,
Dmitri V. Krysko,
Peter Vandenabeele,
Peter de Witte,
and Patrizia Agostinis
|
| 29284-29284 |
Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies
Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies |
|
https://doi.org/10.18632/oncotarget.25726
Fuling Ma,
Liang Dai,
Zhun Wang,
Liqun Zhou,
Yuanjie Niu,
and Ning Jiang
|
| 29285-29285 |
